Drug Developer’s Fraud, Trade Secret Claims Survive Competitor’s Dismissal Bid

Mealey's (May 18, 2020, 2:05 PM EDT) -- CHICAGO — In a May 13 opinion, a federal judge in Illinois ruled that a drug development company pleaded with sufficient particularity that it took reasonable efforts to maintain the secrecy...
To view the full article, register now.